Journal profile · PHARMACOLOGY & PHARMACY
Reviews on Recent Clinical Trials
ISSN 1574-8871 · eISSN 1876-1038 · Bentham
Reviews on Recent Clinical Trials: CAS Zone 4 · Medicine (2025 upgraded edition); subscription journal; median 108 days to acceptance (78 articles, last 24 months); 55 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Reviews on Recent Clinical Trials is published by Bentham and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Statistical Methods in Clinical Trials, Ethics in Clinical Research and Anorectal Disease Treatments and Outcomes, together about 18.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Statistical Methods in Clinical TrialsMathematics6.5%
- Ethics in Clinical ResearchMedicine6%
- Anorectal Disease Treatments and OutcomesMedicine5.8%
- Pelvic floor disorders treatmentsMedicine5.6%
- Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology4.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.5%
- Lung Cancer Diagnosis and TreatmentMedicine4.5%
- Alcohol Consumption and Health EffectsMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Medicine | Q2 | 226/669 | 66th |
| Pharmacology | Q3 | 229/328 | 30th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.6LetPub ·
- SJR 2026-06
- 0.33LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 288OpenAlex ·
- 2-year mean citedness
- 1.16OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 4%LetPub ·
Volume
- Articles per year
- 48LetPub ·
Articles by year OpenAlex count · 911 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 68 | 2 | 460 |
| 2025 | 55 | 6 | 771 |
| 2024 | 36 | 2 | 796 |
| 2023 | 41 | 7 | 860 |
| 2022 | 40 | 1 | 854 |
| 2021 | 55 | 10 | 807 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
108 daysMedian, submission to acceptance · P25–P75 85 days – 142 days
- Acceptance to online
- median 145 days (78 articles)
- Submission to online
- median 269 days
- Sample
- 78 articles with submission and acceptance dates (140 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1574-8871
- Electronic ISSN
- 1876-1038
FAQ
Frequently asked questions about Reviews on Recent Clinical Trials
What CAS zone is Reviews on Recent Clinical Trials in?
In the 2025 upgraded edition of the CAS Journal Ranking, Reviews on Recent Clinical Trials is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Reviews on Recent Clinical Trials?
Based on the dates recorded on 78 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 108 days (interquartile range 85–142 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Reviews on Recent Clinical Trials?
According to LetPub and DOAJ records, Reviews on Recent Clinical Trials is indexed in ESCI and Scopus.
Is Reviews on Recent Clinical Trials open access, and what is the APC?
Reviews on Recent Clinical Trials is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .